Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO) - IDIBELL, l'Hospitalet de Llobregat, Spain; Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP CB06/02/0073), Madrid, Spain.
Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO) - IDIBELL, l'Hospitalet de Llobregat, Spain.
Prev Med. 2021 Mar;144:106399. doi: 10.1016/j.ypmed.2020.106399. Epub 2020 Dec 31.
WHO/UNICEF estimates for HPV vaccination coverage from 2010 to 2019 are analyzed against the backdrop of the 90% coverage target for HPV vaccination by 2030 set in the recently approved global strategy for cervical cancer elimination as a public health problem. As of June 2020, 107 (55%) of the 194 WHO Member States have introduced HPV vaccination. The Americas and Europe are by far the WHO regions with the most introductions, 85% and 77% of their countries having already introduced respectively. A record number of introductions was observed in 2019, most of which in low- and middle- income countries (LMIC) where access has been limited. Programs had an average performance coverage of around 67% for the first dose and 53% for the final dose of HPV. LMICs performed on average better than high- income countries for the first dose, but worse for the last dose due to higher dropout. Only 5 (6%) countries achieved coverages with the final dose of more than 90%, 22 countries (21%) achieved coverages of 75% or higher while 35 (40%) had a final dose coverage of 50% or less. When expressed as world population coverage (i.e., weighted by population size), global coverage of the final HPV dose for 2019 is estimated at 15%. There is a long way to go to meet the 2030 elimination target of 90%. In the post-COVID era attention should be paid to maintain the pace of introductions, specially ensuring the most populous countries introduce, and further improving program performance globally.
分析了 2010 年至 2019 年世卫组织/联合国儿童基金会(UNICEF)针对 HPV 疫苗接种覆盖率的估计数据,这些数据是在最近批准的全球消除宫颈癌作为公共卫生问题战略中设定的 2030 年 HPV 疫苗接种覆盖率达到 90%的目标背景下进行的。截至 2020 年 6 月,194 个世卫组织会员国中有 107 个(55%)已推出 HPV 疫苗接种。美洲和欧洲是世卫组织中实施 HPV 疫苗接种最多的地区,分别有 85%和 77%的国家已实施该计划。2019 年实施的国家数量创下历史新高,其中大多数是在获得 HPV 疫苗接种的机会有限的中低收入国家。这些项目的首剂平均接种率约为 67%,最后一剂的接种率约为 53%。中低收入国家在首剂接种方面的表现平均优于高收入国家,但在最后一剂接种方面表现较差,因为失访率较高。只有 5 个(6%)国家的最后一剂接种覆盖率超过 90%,22 个国家(21%)的覆盖率达到 75%或更高,而 35 个国家(40%)的最后一剂接种覆盖率低于 50%。如果用世界人口覆盖率(即按人口规模加权)来表示,2019 年全球最后一剂 HPV 疫苗的覆盖率估计为 15%。要实现 2030 年消除 90%的目标还有很长的路要走。在后 COVID-19 时代,应注意保持引入的步伐,特别是确保人口最多的国家引入,并进一步提高全球计划的绩效。